Large-scale testing (Phase 3)Study completedNCT01892436
What this trial is testing
Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis
Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 460
Showing 20 of 0 results